Article Information
History
- December 6, 2020.
Article Versions
- Version 1 (December 4, 2020 - 07:43).
- Version 2 (December 4, 2020 - 11:13).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Sina Rüeger1,2,#,
- Christian Hammer3,#,
- Alexis Loetscher2,4,#,
- Paul J McLaren5,6,
- Dylan Lawless1,2,
- Olivier Naret1,2,
- Daniel P. Depledge7,
- Sofia Morfopoulou7,
- Judith Breuer7,
- Evgeny Zdobnov2,4,
- Jacques Fellay1,2,8,*,
- Swiss HIV Cohort Study
- 1School of Life Sciences, EPFL, Lausanne, Switzerland
- 2Swiss Institute of Bioinformatics, Switzerland
- 3Genentech Inc, 1 DNA Way, South San Francisco, CA, USA
- 4Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
- 5JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, MB, Canada
- 6Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada
- 7Division of Infection and Immunity, University College London, London, UK
- 8Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Switzerland
- ↵*Correspondence to jacques.fellay{at}epfl.ch.
↵# These authors contributed equally to this work.
Posted December 06, 2020.
The influence of human genetic variation on Epstein-Barr virus sequence diversity
